RXRX

Recursion Pharmaceuticals Inc

Price

$4.06

return (12m)

-26.05%

p/e

-4.17

p/bv

2.36

DIVIDEND YIELD

0.00%

RXRX price

Recursion Pharmaceuticals Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RXRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.92%

3 months

3.04%

1 year

-26.05%

2 years

-33.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals RXRX

Valuation

P/E

-4.17

Sector 7.50

Industry 7.50

P/BV

2.36

Sector 1.77

Industry 1.77

P/Revenue (PSR)

39.41

Sector 1.72

Industry 1.72

EV/EBITDA

-14.40

Sector -842.79

Industry -842.79

EV/EBIT

-12.40

Sector -1,519.48

Industry -1,519.48

P/EBITDA

-4.87

Sector -14.40

Industry -14.40

P/EBIT

-4.14

Sector -12.63

Industry -12.63

P/Total Assets

1.78

Sector 0.83

Industry 0.83

P/Net Current Assets

7.07

Sector -1.96

Industry -1.96

P/Working Capital

4.47

Sector -4,656.37

Industry -4,656.37

EPS

-0.97

Sector 0.70

Industry 0.70

BVPS

1.72

Sector 9.63

Industry 9.63

Efficiency

Gross Margin

3.48%

Sector 35.53%

Industry 35.53%

EBITDA Margin

-1,467.14%

Sector -7,056,892.18%

Industry -7,056,892.18%

EBIT Margin

-1,704.00%

Sector -159.46%

Industry -159.46%

Operating Margin

-100.00%

Sector 4.35%

Industry 4.35%

Net Profit Margins

-100.00%

Sector 2.37%

Industry 2.37%

Asset Turnover

0.01

Sector 0.11

Industry 0.11

Profitability

ROE

-56.71%

Sector 2.14%

Industry 2.14%

ROA

-42.79%

Sector -0.82%

Industry -0.82%

ROIC

-78.30%

Sector -120.08%

Industry -120.08%

Dividends

Dividend yield

0.00%

Sector 0.53%

Industry 0.53%

Payout

Sector 10.02%

Industry 10.02%

Debt

Current Ratio

5.03

Sector 1.47

Industry 1.47

Net Debt / EBITDA

4.81

Sector -20.49

Industry -20.49

Net Debt / EBIT

4.14

Sector -168,192,801.50

Industry -168,192,801.50

Net Debt / Equity

-0.59

Sector -0.78

Industry -0.78

Gross Debt / Equity

0.01

Sector -0.51

Industry -0.51

Equity/Assets

0.75

Sector 0.43

Industry 0.43

Liabilities/Assets

0.25

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

40.06%

Sector -

Industry -

5Y Earnings CAGR

22.71%

Sector -

Industry -

Fundamentals RXRX

DRAG THE FRAME TO SEE MORE DATA

RXRX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc

Average Investor10 user rating

4.0 (11 people)

United States

- year

Founded:

2021

Time since IPO - 5 years

600

Employees

Recursion Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $2.16 billion, with shareholders equity totaling $915.00 million.

The company employs approximately 600 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Recursion Pharmaceuticals Inc reported $54.86 million in revenue, generating net income of $-518.88 million.

Key financial metrics include a P/E ratio of -4.17, a price-to-book (P/B) ratio of 2.36, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RXRX.

Market cap

$2.16 billion

Net worth

$915.00 million

$915,003,000.00

Assets

$1.21 billion

$1,212,668,000.00

Total Shares Outstanding

532.46 million

532,460,000

Average Daily Trading Volume

$17.90 million

$17,901,484.00

Sector

Others

Industry

Others

RXRX

RXRX revenue and profits

Financial Results RXRX

DRAG THE FRAME TO SEE MORE DATA

RXRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$368.07 4,90% (12M)

P/E

23.51

2.46%

ROE

13.51%

P/BV

3.18

SHEL - Shell PLC ADR

$95.74 35,65% (12M)

P/E

10.30

3.16%

ROE

14.29%

P/BV

1.47

STLA - Stellantis NV

$4.37 --59,26% (12M)

P/E

-0.50

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$307.21 2,24% (12M)

P/E

22.61

0.78%

ROE

81.03%

P/BV

18.32

ALIZY - Allianz SE ADR

$46.75 --19,31% (12M)

P/E

12.88

2.91%

ROE

17.89%

P/BV

2.30

TTE - TotalEnergies SE ADR

$84.50 48,84% (12M)

P/E

6.86

4.78%

ROE

21.42%

P/BV

1.47

NSRGY - Nestle SA ADR

$90.02 0,79% (12M)

P/E

10.81

4.45%

ROE

58.05%

P/BV

6.27

ELV - Elevance Health Inc

$386.86 12,56% (12M)

P/E

19.87

1.71%

ROE

9.84%

P/BV

1.96